BOOTHBAY FUND MANAGEMENT, LLC - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 66 filers reported holding GEMINI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$71,000
+20.3%
42,2970.0%0.00%
+100.0%
Q1 2022$59,000
-52.0%
42,2970.0%0.00%
-66.7%
Q4 2021$123,000
-75.2%
42,297
-65.4%
0.00%
-78.6%
Q3 2021$495,000
+60.2%
122,397
+156.6%
0.01%
+40.0%
Q2 2021$309,000
-70.2%
47,702
-37.7%
0.01%
-74.4%
Q1 2021$1,037,00076,5510.04%
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 2,435,125$9,838,0003.06%
Asymmetry Capital Management, L.P. 284,079$1,148,0000.69%
Orbimed Advisors 5,826,224$23,538,0000.26%
Boxer Capital, LLC 1,300,000$5,252,0000.18%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,137,823$8,637,0000.15%
Ikarian Capital, LLC 421,050$1,701,0000.12%
JS Capital Management LLC 474,457$1,917,0000.11%
PURA VIDA INVESTMENTS, LLC 494,400$1,997,0000.06%
HARVARD MANAGEMENT CO INC 250,000$1,010,0000.06%
Atom Investors LP 102,792$415,0000.03%
View complete list of GEMINI THERAPEUTICS INC shareholders